A morning blood pressure surge (MBPS) may be either a mechanism for, or a marker of, increased cardiovascular events. This study has examined factors which may influence the morning surge: age, gender, metabolic factors, sympathetic function, blood pressure and arterial stiffness. Four measures of the MBPS were examined-sleep-trough surge, pre-awake surge, rate of blood pressure rise and a Power function. Subjects underwent ambulatory blood pressure monitoring, glucose tolerance test, central pulse wave velocity, sympathetic autonomic function tests (mental stress and sustained handgrip). MBPS was associated with age, hypertension, blood pressure variability and serum lipids. After adjustment for age and waist circumference, all four measures of MBPS remained positively associated with low-density lipoprotein (LDL) cholesterol. The novel finding of a significant relationship between measures of MBPS and LDL-cholesterol is an intriguing link between two major cardiovascular risk factors.
INTRODUCTION
Cardiovascular events and sudden cardiac death display a circadian pattern with the peak incidence occurring in the morning period. 1, 2 It is postulated that an exaggerated morning blood pressure surge (MBPS) may explain this finding. 3 The most widely used definitions of a MBPS are the sleeptrough surge and the pre-waking surge, 3, 4 both of which are calculated from differences of blood pressure averages over specific time-intervals around waking. A MBPS, by either definition, has been found to be associated with incident cardiovascular events. 5, 6, 7, 8 In a study of elderly hypertensive subjects who had undergone carotid endarterectomy for asymptomatic high-grade lesions, Marfella et al., 9 found that patients with an exaggerated MBPS had unstable atherosclerotic lesion phenotypes compared with those that did not.
Head et al. 10 proposed a mathematical approach, using a double logistic curve fitting technique that models the rate of MBPS to define a rate of morning blood pressure rise (RoR). Head et al. 11 further determined the 'Power' of the MBPS as the product of the RoR with the day-night blood pressure difference. The RoR has not been validated against cardiovascular event outcome data, whereas the Power function was associated with reduced mortality in a post-hoc analysis of the Second Australian National Blood Pressure study-ANBP2. 12 The mechanism(s) underlying the rate of MBPS have not been clearly defined. Potential contributors include sympathetic activity 13 and/or activation of the renin-angiotensin system. 14 In the present study, we examine a range of factors, including age, sex, metabolic factors, sympathetic function, blood pressure and central arterial stiffness, using four measures of the MBPS, to assess which factor/s are consistently associated across the measures of the MBPS. This study also examines the four measures of the MBPS in subjects with normotension, whitecoat hypertension and newly diagnosed hypertension.
MATERIALS AND METHODS
The study was approved by the institutional human research ethics committee. Adult subjects (40-75 years) were recruited by advertisement in local newspapers and through an ambulatory blood pressure monitoring (ABPM) service, which receives referrals from 120 general practitioners.
Subjects were excluded if they were smokers, had known diabetes, were taking anti-hypertensive medication or had existing liver, renal or cardiovascular disease or any malignancy. Written informed consent was obtained from all the subjects.
Subjects presented in the morning, after a minimum 10 h fast. Each subject completed a questionnaire about previous and present illnesses, family history, medication, diet, physical activity and alcohol habits. Alcohol consumption was categorised into none, mild (one to two standard drinks on any day) or heavy (more than two standard drinks on any day). The metabolic syndrome was defined according to the criteria set out by the International Diabetic Federation Task Force. 15 Glucose status was defined as per World Health Organisation definitions. 16 Ambulatory blood pressure monitoring ABPM was performed using a portable device (Meditech Cardiotens, Meditech Ltd, Hungary). ABPM cuff was placed on the non-dominant arm and automatic blood pressure recordings were programmed to occur at 30 min intervals day and night. Normotension was defined as reported clinic blood pressure o140/90 mm Hg and day 24 h ABPM o135/ 85 mm Hg and night ABPM o120/70 mm Hg. White-coat hypertension was defined as reported clinic blood pressure X140/90 mm Hg and day 24 h ABPM o135/85 mm Hg and night ABPM o120/70 mm Hg. Repeat 24 h ABPM within a 12-month period was required in all subjects with white-coat hypertension to confirm this diagnosis. Sustained hypertension was defined as reported clinic X140/90 mm Hg and day 24 h ABPM X135/ 85 mm Hg or night ABPM X120/70 mm Hg.
Recordings were not included in the analysis if reported sleep duration was o5 h, if more than one blood pressure recording was missing in the pre-awake or post-awake period, or if there was missing recordings contiguous to the lowest systolic blood pressure (SBP) recorded during sleep. Recordings were also excluded if o10 SBP readings were recorded during the sleep period.
Morning blood pressure surge
The sleep-trough MBPS was defined as the morning SBP minus the lowest night-time SBP, where the morning SBP was defined as the average of four 30 min SBP readings just after waking and the lowest night-time SBP was the 1 h average of three SBPs readings centred on the lowest night-time reading.
The pre-awake MBPS was defined as the morning SBP minus the preawake SBP, where the pre-awake SBP was the average of four 30 min SBP readings just before wakening.
The morning SBP RoR and the Power function were calculated according to the method of Head et al. 18 Assessment of sympathetic function Autonomic function testing was performed using the Task Force monitor, CNSystems, Graz, Austria. After resting for 2 min an oscillometric blood pressure was taken. Subjects were then instructed to subtract out loud the value 13 from the value 4300. Subjects were instructed to either start again or continue from the current value if they felt they had made a mistake and that no assistance would be given by the examiner. If a subject verbalised an inability to do this subtraction then they were offered the subtraction of 13 from 430. An oscillometric blood pressure measurement was taken at 1 min. The difference in systolic and diastolic blood pressures at 1 min, from the resting systolic and diastolic blood pressures was calculated.
After resting for 2 min an oscillometric blood pressure was taken. Subjects were asked to squeeze a partially inflated cuff connected to a sphygmomanometer and the maximal pressure was noted. Subjects were then asked to squeeze the cuff to one-third of the noted maximum pressure for 5 min, and oscillometric blood pressure measurements were taken on the other arm at 1 min intervals. The difference between resting diastolic blood pressure and the maximum diastolic blood pressure during sustained handgrip was determined.
Central pulse wave velocity
Central aorto-femoral PWV (PWVc) measurements were performed by the same two operators (CAM, SSC), in a quiet air-conditioned room after 10 min of rest and with the subject lying supine. Continuous pulse pressure wave signals were recorded with hand-held tonometers (Millar Mikro-tip, SPT-301; Millar Instruments, Houston, TX, USA) positioned at the base of the right common carotid artery and over the right common femoral artery. Transit distance was defined as the measured distance from the sternal notch to femoral artery minus distance from sternal notch to carotid. The start of systole was defined by the local maximum of the first derivative of the pressure signal. Mean transit time (Dt) between the feet of simultaneously recorded waves was determined from 10 consecutive cardiac cycles. Mean arterial pressure was estimated from an oscillometric blood pressure measurement taken immediately post recording of the arterial waveforms.
Biochemical measures
Blood samples were taken under fasting conditions, following which subjects consumed a 75-g glucose solution over a period of 5 min. Plasma glucose was measured at 120 min post glucose load (2hPG). Blood samples were processed immediately after collection. Plasma glucose was analysed by the glucose oxidase method.
Plasma samples for fasting total plasma cholesterol, triglycerides, lowdensity lipoprotein (LDL-cholesterol) and high-density lipoprotein (cholesterol) were analysed immediately, whereas plasma for high-sensitivity C-reactive protein and Leptin were stored at À 70 0 C until analysis. Commercial assay kits were used for these analyses.
Statistical analysis STATA, version 10, (StataCorp LP, College Station, TX, USA) was used to analyse the data. Normally distributed data is expressed as mean±s.d., whereas skewed data is expressed as median (interquartile range). Categorical data is expressed as percentages. Non-normal data was transformed before analysis. All comparisons were two-sided. Univariate and multivariate linear regression was used to analyse continuous variables, whereas the chi-squared (w 2 ) or Fischer's exact test was used to analyse categorical variables. Univariate and multivariate logistic regression was used to analyse the dichotimisation of each measure of the MBPS at the 90th percentile. Each outcome variable was examined for potential confounders. Analysis of outcome variable was adjusted for each confounder. To prevent co-linearity between related variables, such as the lipid variables, the strongest linearly associated related variable was included in the model. Assessment of MBPS measures, which involved measures of differences, (sleep-trough and pre-awake), were correlated against their baseline measure to assess for regression to the mean. The baseline measures were included in regression analysis if regression to the mean was present. For data, which required log transformation, that contained negative values, the minimum value of the data plus one was added to each value before transformation, to anchor the log-transformed data on zero. The minimum value, plus one, was removed from the backtransformed data to determine the geometric mean. Statistical significance was considered to be met at a ¼ 0.05.
RESULTS
One hundred and twenty-two participants met the study criteria. Fifteen participants (12%) were excluded from the analysis as four reported sleep times of o5 h and 11 participants had insufficient night or morning SBP readings. Thirty-eight normotensive subjects, 28 white-coat hypertensive subjects and 42 newly diagnosed, untreated hypertensive subjects remained in the analysis. Three subjects had a mean night SBP greater than their mean day SBP. These subjects were excluded from the analysis of the modelled rate of MBPS and its Power function.
As shown in Table 1 , subject characteristics, PWVc, sympathetic function and plasma biochemistry were similar in the normotensive and white-coat hypertensive groups, except for an increase in the 2hPG in the white-coat hypertensive group.
The sustained hypertensive group was statistically different from the normotensive and white-coat hypertensive groups with regard to a higher male to female ratio, greater waist circumference, higher triglycerides, lower high-density lipoprotein-cholesterol and the presence of the metabolic syndrome. The sustained hypertensive group had a higher diastolic blood pressure response to the grip-test compared with white-coat hypertensive group (P ¼ 0.04) but not compared with the normotensive group. The sustained hypertensive group had a borderline significantly different high-sensitivity C-reactive protein compared with the normotensive group. PWVc, adjusted for mean arterial pressure, was significantly higher in the sustained hypertensive group compared with the normotensive group.
Analysis of the 24-h ABP measurements in the three groups is reported in Table 2 . The recorded sleep time was similar in the three groups. The sustained hypertensive group had significantly higher day, night and 24 h s.d. of SBP, as well as higher night minimum average SBP, pre-awake SBP and morning SBP compared with the normotensive and the white-coat hypertensive groups. No difference was found in these measures between the white-coat hypertensive and normotensive groups.
MBPS measurements
The sleep-trough MBPS was right skewed and ranged from À 6 to 56 mm Hg, (median 17, interquartile range: 11-26, 90th percentile 33.2 mm Hg). The pre-awake MBPS was normally distributed, ranging from À 13 to 43 mm Hg, (mean ± s.d.: 13 ± 10, 90th percentile 27.3 mm Hg). The RoR was extremely right skewed and ranged from 0.5 to 39. After adjustment for age, waist circumference, menopause, ABPM day SBP, LDL-cholesterol remained significantly associated with the sleep-trough MBPS (P ¼ 0.01), the pre-awake MBPS (P ¼ 0.003), RoR (P ¼ 0.045) and the Power function (P ¼ 0.007).
Analysis of the dichotomised MBPS measures
The dichotomisation of MBPS measures at the 90th percentile created binary variables with 11 subjects in the top 10%. Subjects in the top 10% of the sleep-trough (odds ratio 2.6, 95% confidence interval (CI): 1.4-4.9) and the pre-awake (odds ratio 2.4, 95% CI: 1.3-4.4) MBPS were more likely to have an elevated LDLcholesterol than subjects in the lower 90% (Table 3) . This difference remained significant after adjusting for potential confounders including age, menopausal status, gender and ABPM day SBP. There was no significant difference between LDL levels for subjects in the top decile of the RoR, or the Power function and subjects in the lower 90%.
Both the sleep-trough MBPS and the pre-awake MBPS were associated with their baseline measure (lowest night-time SBP for Adjusted for mean arterial pressure.
Morning blood pressure surge and cholesterol CA Martin et al the sleep-trough MBPS and pre-awake SBP for the pre-awake MBPS) suggesting regression to the mean. None of the four measures of MBPS were associated with sex, alcohol use, waist, body mass index, PWVc, fasting plasma glucose or the 2-h plasma glucose post oral glucose load, high-sensitivity C-reactive protein, leptin, sleep duration, grip or mental stress tests.
MBPS across blood pressure groups
These results are shown in Table 4 . After adjusting the sleeptrough MBPS for age and age 2 , LDL-cholesterol and the night minimum SBP no significant difference was found between the normotensive and white-coat hypertensive groups, P ¼ 0.23, whereas a significant difference was found between the sustained hypertensive and the normotensive groups (Po0.001) and between the sustained hypertensive and white-coat hypertensive groups (P ¼ 0.003). Estimated, adjusted sleep-trough MBPS was 13 mm Hg (95% CI: 11-15 mm Hg) for the normotensive group, 15 mm Hg (95% CI: 12-18 mm Hg) for the white-coat hypertensive group and 23 mm Hg (95% CI: 19-28 mm Hg) for the sustained hypertensive group. Adjusting the pre-awake MBPS for age and age 2 , LDLcholesterol and the pre-awake SBP no significant difference was found between the normotensive and white-coat hypertensive groups (P ¼ 0.12), whereas a significant difference was found between the sustained hypertensive and the normotensive groups (Po0.001), and between the sustained hypertensive and white-coat hypertensive groups (P ¼ 0.004). Estimated, adjusted pre-awake MBPS was 8 mm Hg (95% CI: 5-11 mm Hg) for the normotensive group, 11 mm Hg (95% CI: 8-15 mm Hg) for the white-coat hypertensive group and 19 mm Hg (95% CI: 16-22 mm Hg) for the sustained hypertensive group.
Adjusting the RoR by LDL-cholesterol and the night SBP, no difference was found for the adjusted RoR between the normotensive and white-coat hypertensive groups, or the whitecoat hypertensive and sustained hypertensive groups, whereas a significant was found between the adjusted RoR between the normotensive and sustained hypertensive groups. 
DISCUSSION
In our study we found in an untreated population, significant linear associations across all four measures of the MBPS and LDL-cholesterol. This consistent finding could not be explained by waist circumference, age, blood pressure or menopause status, all of which are potential confounders.
3,19 A significant positive relationship was found for both the RoR and the Power function with fasting total cholesterol and LDL-cholesterol in a study, which was presented to the 23rd meeting of the International Society of Hypertension. (Head GA, Andrianopoulos N, Reid C, McGrath B, Martin C, La Greca C, Chatzivlastou K, unpublished work, 2010) In a meta-analysis of eight studies, which included 5645 patients, Li et al. 6 reported that the top decile of the sleeptrough MBPS had higher mean total cholesterol compared with the rest of the study population.
Similarly, in the present study the top deciles of the sleeptrough and pre-awake MBPS had higher mean fasting LDLcholesterol compared with the lower 90 per cent, but this did not hold for the RoR or the Power function. This could be due to the small sample size and the loss of information and power that occurs when continuous variables are categorised. 20 Two outcome studies of the MBPS in hypertensive subjects, reported similar lipid profiles in the MBPS and non-MBPS groups. 5, 7 Several studies have shown subjects with an elevated MBPS tend to be older than those with a lower MBPS. 6, 21 Lee et al.
22
found age was linearly associated with the sleep-trough MBPS in untreated hypertensive subjects. Head et al. 11 found a relationship between age and the RoR and the Power function, although the relationship could be described as weak.
A number of studies have examined factors that may potentially contribute to MBPS. A positive relationship has been reported for fasting plasma glucose and MBPS. 23 Conflicting results have been found between measures of sympathetic activity and MBPS. [24] [25] [26] Polonia et al. 27 in a study of 711 subjects, which included treated hypertensives and diabetics, found a significant correlation between PWV and the MBPS. The present study found no significant relationships between metabolic factors, sympathetic function or PWV and any of the measures of the MBPS.
Two studies have assessed the MBPS in a white-coat hypertensive population. 11, 28 Polonia et al., 28 using the sleeptrough as a measure of MBPS, with subjects matched for age gender and weight, found a higher MBPS and day time variability in white-coat hypertensive compared with the normotensive. However, the definition of white-coat hypertensive in that study was based on a single 24-h ABP recording. Moreover the results did not take into account different baseline measurements. The sleep-trough surge and the pre-awake surge both require adjustment for their baseline measure to take into account the regression to the mean. The present study found no differences between white-coat hypertension and the normotensive group for any of the four measures of MBPS.
There are limitations to this study. The subjects were not randomly selected, with all the normotensives recruited by advertisement, whereas the majority of white-coat hypertensive and sustained hypertensive subjects were recruited from our ABPM service. There was also a predominance of female subjects. However, subjects were all drawn from the same geographic area. Information of morning activity was not obtained in study subjects.
The novel finding of a significant relationship between measures of MBPS and fasting LDL-cholesterol in a population of untreated subjects is an intriguing link between the two major cardiovascular risk factors. The factor(s) responsible for this linkage have yet to be defined.
What is known about this topic
An increased morning blood pressure rise is associated with incident cardiovascular events.
The morning blood pressure rise, by a variety of definitions, has been shown to be associated with cardiovascular events, particularly stroke. Factors associated with the morning blood pressure rise have previously been identified. Non-modifiable factors: age Modifiable risk factors: hypertension, blood pressure variability, sympathetic activity and fasting glucose.
What this study adds A comprehensive analysis of several measures of the MBPS and cardiovascular risk factors. The present study confirmed that age, blood pressure variability and sustained hypertension were related to the MBPS. The novel finding in the present study was the significant positive correlation between measures of the MBPS and serum lipids.
